Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Indaptus Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $123.05M | $123.05M - $123.05M | $0.00 | $6.40 | 1 |
| Dec 2028 | $42.39M | $42.39M - $42.39M | $0.00 | $0.79 | 1 |
| Dec 2027 | $0.00 | $0.00 - $0.00 | $0.00 | -$4.42 | 0 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$6.34 | 0 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$20.79 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$47.88 | 0 |
| Dec 2021 | $25.00M | $25.00M - $25.00M | $0.00 | -$130.34 | 1 |
| Dec 2019 | $750.0K | $750.0K - $750.0K | $0.00 | -$3,001.60 | 1 |